In aggressive forms of mastocytosis, TET2 loss cooperates with c-KITD816V to transform mast cells

被引:84
作者
Soucie, Erinn [1 ]
Hanssens, Katia [1 ]
Mercher, Thomas [2 ]
Georgin-Lavialle, Sophie [3 ,4 ,5 ]
Damaj, Gandhi [6 ]
Livideanu, Cristina [7 ]
Chandesris, Maria Olivia [3 ,8 ]
Acin, Yolene [9 ]
Letard, Sebastien [1 ]
de Sepulveda, Paulo [1 ]
Hermine, Olivier [3 ,4 ,8 ]
Bernard, Olivier A. [2 ]
Dubreuil, Patrice [1 ]
机构
[1] Univ Mediterranee, INSERM, Inst J Paoli I Calmettes, Ctr Rech Cancerol Marseille,U1068,Ctr Reference M, F-13273 Marseille 09, France
[2] Univ Paris 11, Inst Gustave Roussy, INSERM, U985, Villejuif, France
[3] Univ Paris 05, Hop Necker Enfants Malad, Ctr Reference Mastocytoses, Paris, France
[4] CNRS, Unite Mixte Rech 8147, Paris, France
[5] Hop Europeen Georges Pompidou, Serv Med Interne, Paris, France
[6] Ctr Hosp Univ, Dept Hematol, Amiens, France
[7] Hop Larrey, Toulouse, France
[8] Hop Necker Enfants Malad, Serv Hematol Adulte, Paris, France
[9] AB Sci, Paris, France
关键词
PEDIATRIC MASTOCYTOSIS; SELF-RENEWAL; C-KIT; MUTATIONS; DIFFERENTIATION;
D O I
10.1182/blood-2011-12-397588
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although a role for oncogenic KIT in driving mast cell disease is clear, the mechanisms driving the multiple phenotypic and clinical manifestations of this disorder are not well elucidated. We now show, using a large cohort of mastocytosis patients, including an almost equal number of aggressive and nonaggressive cases of systemic mastocytosis, that in contrast to the oncogenic KITD816V, TET2 mutation statistically associates with aggressive forms of the disease. By infecting primary murine bone marrow-derived mast cells with KITD816V, we also observe a significant and competitive growth advantage for KITD816V in Tet2-nullizygous compared with wild-type cells. TET2-deficient cells display in-creased proliferation and can survive in the absence of cytokines. Taken together, these data demonstrate a oncogenic cooperation in mast cells and reveal TET2 mutation as a potential marker to diagnose and predict severe forms of mastocytosis. (Blood. 2012;120(24):4846-4849)
引用
收藏
页码:4846 / 4849
页数:4
相关论文
共 20 条
[1]   Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies [J].
Abdel-Wahab, Omar ;
Mullally, Ann ;
Hedvat, Cyrus ;
Garcia-Manero, Guillermo ;
Patel, Jay ;
Wadleigh, Martha ;
Malinge, Sebastien ;
Yao, JinJuan ;
Kilpivaara, Outi ;
Bhat, Rukhmi ;
Huberman, Kety ;
Thomas, Sabrena ;
Dolgalev, Igor ;
Heguy, Adriana ;
Paietta, Elisabeth ;
Le Beau, Michelle M. ;
Beran, Miloslav ;
Tallman, Martin S. ;
Ebert, Benjamin L. ;
Kantarjian, Hagop M. ;
Stone, Richard M. ;
Gilliland, D. Gary ;
Crispino, John D. ;
Levine, Ross L. .
BLOOD, 2009, 114 (01) :144-147
[2]   Pediatric Mastocytosis Is a Clonal Disease Associated with D816V and Other Activating c-KIT Mutations [J].
Bodemer, Christine ;
Hermine, Olivier ;
Palmerini, Fabienne ;
Yang, Ying ;
Grandpeix-Guyodo, Catherine ;
Leventhal, Phillip S. ;
Hadj-Rabia, Smail ;
Nasca, Laurent ;
Georgin-Lavialle, Sophie ;
Cohen-Akenine, Annick ;
Launay, Jean-Marie ;
Barete, Stephane ;
Feger, Frederic ;
Arock, Michel ;
Catteau, Benoit ;
Sans, Beatrix ;
Stalder, Jean Francois ;
Skowron, Francois ;
Thomas, Luc ;
Lorette, Gerard ;
Plantin, Patrice ;
Bordigoni, Pierre ;
Lortholary, Olivier ;
de Prost, Yves ;
Moussy, Alain ;
Sobol, Hagay ;
Dubreuil, Patrice .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 (03) :804-815
[3]   Signal transduction by several KIT juxtamembrane domain mutations [J].
Casteran, N ;
De Sepulveda, P ;
Beslu, N ;
Aoubala, M ;
Letard, S ;
Lecocq, E ;
Rottapel, R ;
Dubreuil, P .
ONCOGENE, 2003, 22 (30) :4710-4722
[4]   Mutation in TET2 in Myeloid Cancers [J].
Delhommeau, Francois ;
Dupont, Sabrina ;
Della Valle, Veronique ;
James, Chloe ;
Trannoy, Severine ;
Masse, Aline ;
Kosmider, Olivier ;
Le Couedic, Jean-Pierre ;
Robert, Fabienne ;
Alberdi, Antonio ;
Lecluse, Yann ;
Plo, Isabelle ;
Dreyfus, Francois J. ;
Marzac, Christophe ;
Casadevall, Nicole ;
Lacombe, Catherine ;
Romana, Serge P. ;
Dessen, Philippe ;
Soulier, Jean ;
Viguie, Franck ;
Fontenay, Michaela ;
Vainchenker, William ;
Bernard, Olivier A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (22) :2289-2301
[5]   Constitutively active mutant D816VKit induces megakayocyte and mast cell differentiation of early haemopoietic cells from murine foetal liver [J].
Ferrao, PT ;
Gonda, TJ ;
Ashman, LK .
LEUKEMIA RESEARCH, 2003, 27 (06) :547-555
[6]   IDENTIFICATION OF MUTATIONS IN THE CODING SEQUENCE OF THE PROTOONCOGENE C-KIT IN A HUMAN MAST-CELL LEUKEMIA-CELL LINE CAUSING LIGAND-INDEPENDENT ACTIVATION OF C-KIT PRODUCT [J].
FURITSU, T ;
TSUJIMURA, T ;
TONO, T ;
IKEDA, H ;
KITAYAMA, H ;
KOSHIMIZU, U ;
SUGAHARA, H ;
BUTTERFIELD, JH ;
ASHMAN, LK ;
KANAYAMA, Y ;
MATSUZAWA, Y ;
KITAMURA, Y ;
KANAKURA, Y .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (04) :1736-1744
[7]   KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders:: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients [J].
Garcia-Montero, Andres C. ;
Jara-Acevedo, Maria ;
Teodosio, Cristina ;
Luz Sanchez, Maria ;
Nunez, Rosa ;
Prados, Aranzazu ;
Aldanondo, Isabel ;
Sanchez, Laura ;
Dominguez, Mercedes ;
Botana, Luis M. ;
Sanchez-Jimenez, Francisca ;
Sotlar, Karl ;
Almeida, Julia ;
Escribano, Luis ;
Orfao, Alberto .
BLOOD, 2006, 108 (07) :2366-2372
[8]   Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification [J].
Ito, Shinsuke ;
D'Alessio, Ana C. ;
Taranova, Olena V. ;
Hong, Kwonho ;
Sowers, Lawrence C. ;
Zhang, Yi .
NATURE, 2010, 466 (7310) :1129-U151
[9]   Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2 [J].
Ko, Myunggon ;
Huang, Yun ;
Jankowska, Anna M. ;
Pape, Utz J. ;
Tahiliani, Mamta ;
Bandukwala, Hozefa S. ;
An, Jungeun ;
Lamperti, Edward D. ;
Koh, Kian Peng ;
Ganetzky, Rebecca ;
Liu, X. Shirley ;
Aravind, L. ;
Agarwal, Suneet ;
Maciejewski, Jaroslaw P. ;
Rao, Anjana .
NATURE, 2010, 468 (7325) :839-843
[10]   TET2 mutations in childhood leukemia [J].
Langemeijer, S. M. C. ;
Jansen, J. H. ;
Hooijer, J. ;
van Hoogen, P. ;
Stevens-Linders, E. ;
Massop, M. ;
Waanders, E. ;
van Reijmersdal, S. V. ;
Stevens-Kroef, M. J. P. L. ;
Zwaan, C. M. ;
van den Heuvel-Eibrink, M. M. ;
Sonneveld, E. ;
Hoogerbrugge, P. M. ;
van Kessel, A. Geurts ;
Kuiper, R. P. .
LEUKEMIA, 2011, 25 (01) :189-192